DEFINE AFib (Atrial Fibrillation)
Part of paid clinical trials in Mission Viejo, California.
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Study ID
- NCT04926857
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional — OTHERNon-Interventional
Study Details
DEFINE AFib is a prospective, observational, post-market clinical study administered to patients via the Medtronic Discovery app platform. This study will enroll approximately 5,000 patients in the United States who have a Reveal LINQ or LINQ II ICM (or future market-released LINQ devices) and an Apple® iPhone® with iOS version 13 or higher. Interested participants will be screened through the Medtronic Discovery app and those eligible will complete an app-based informed consent. Participants will receive health-focused and quality of life surveys at variable timepoints. DEFINE AFib will measure healthcare interactions using administered surveys to identify said interactions. The Medtronic Discovery app will provide participants with a summary of their ICM data. Participants will be followed up to 5 years or to the end of their ICM service life.
Key Dates
- Start date
- Jun 21, 2021
- Status verified
- Jul 2025
- Primary completion
- Jan 25, 2024
- Completion
- Jan 25, 2024
Study Design
- Enrollment
- 973 participants (actual)
Primary Outcome Measure
Healthcare Utilization Where AF Was a Reason or a Suspected Reason for the Healthcare Interaction. [ Time Frame: Through study completion (2 years of enrollment, up to 2.6 years of follow-up) ]
Locations (26)
Find similar trials in Mission Viejo, CA
Related Studies
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac SurgeryPHASE2 · Not Yet Recruiting · Baystate Medical Center · Melrose, Massachusetts
- Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial FibrillationPHASE4 · Recruiting · University of Illinois at Chicago · Chicago, Illinois
- Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot StudyPHASE2 · Recruiting · University of South Florida · Tampa, Florida